CARGO THERAPEUTICS INC (CRGX) Stock Price & Overview

NASDAQ:CRGX • US14179K1016

4.47 USD
-0.07 (-1.54%)
At close: Aug 18, 2025
4.47 USD
0 (0%)
After Hours: 8/18/2025, 9:25:47 PM

The current stock price of CRGX is 4.47 USD. Today CRGX is down by -1.54%. In the past month the price decreased by -1.11%. In the past year, price decreased by -75.1%.

CRGX Key Statistics

52-Week Range3 - 25.45
Current CRGX stock price positioned within its 52-week range.
1-Month Range4.4 - 4.57
Current CRGX stock price positioned within its 1-month range.
Market Cap
216.169M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-3.66
Dividend Yield
N/A

CRGX Stock Performance

Today
-1.54%
1 Week
-0.22%
1 Month
-1.11%
3 Months
+9.02%
Longer-term
6 Months +18.57%
1 Year -75.10%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

CRGX Stock Chart

CARGO THERAPEUTICS INC / CRGX Daily stock chart

CRGX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CRGX. When comparing the yearly performance of all stocks, CRGX is a bad performer in the overall market: 93.99% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
CRGX Full Technical Analysis Report

CRGX Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to CRGX. CRGX has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CRGX Full Fundamental Analysis Report

CRGX Earnings

Next Earnings DateNov 10, 2025
Last Earnings DateAug 6, 2025
PeriodQ2 / 2025
EPS Reported-$1.04
Revenue Reported
EPS Surprise -65.12%
Revenue Surprise %
CRGX Earnings History

CRGX Forecast & Estimates

11 analysts have analysed CRGX and the average price target is 5.61 USD. This implies a price increase of 25.5% is expected in the next year compared to the current price of 4.47.


Analysts
Analysts49.09
Price Target5.61 (25.5%)
EPS Next Y21.22%
Revenue Next YearN/A
CRGX Forecast & Estimates

CRGX Groups

Sector & Classification

CRGX Financial Highlights

Over the last trailing twelve months CRGX reported a non-GAAP Earnings per Share(EPS) of -3.66. The EPS increased by 92.79% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-221.78M
Industry RankSector Rank
PM (TTM) N/A
ROA -85.76%
ROE -93.3%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-1.96%
Sales Q2Q%N/A
EPS 1Y (TTM)92.79%
Revenue 1Y (TTM)N/A
CRGX financials

CRGX Ownership

Ownership
Inst Owners98.83%
Shares48.36M
Float48.11M
Ins Owners0.35%
Short Float %N/A
Short RatioN/A
CRGX Ownership

CRGX Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC16417.437B
AMGN AMGEN INC16.31204.229B
GILD GILEAD SCIENCES INC16.27183.894B
VRTX VERTEX PHARMACEUTICALS INC22.6121.25B
REGN REGENERON PHARMACEUTICALS16.4783.255B
ALNY ALNYLAM PHARMACEUTICALS INC47.8443.24B
INSM INSMED INC N/A31.965B
NTRA NATERA INC N/A28.775B
BIIB BIOGEN INC12.3627.876B
MRNA MODERNA INC N/A22.581B
UTHR UNITED THERAPEUTICS CORP16.2421.486B
RVMD REVOLUTION MEDICINES INC N/A20.053B
EXAS EXACT SCIENCES CORP308.8219.749B

About CRGX

Company Profile

CRGX logo image Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.

Company Info

CARGO THERAPEUTICS INC

835 Industrial Road, Suite 400

San Carlos CALIFORNIA US

Employees: 167

CRGX Company Website

CRGX Investor Relations

Phone: 16504998950

CARGO THERAPEUTICS INC / CRGX FAQ

What does CARGO THERAPEUTICS INC do?

Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. The company is headquartered in San Carlos, California and currently employs 167 full-time employees. The firm's programs, platforms, and manufacturing strategy were designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. A CAR is an engineered protein that is delivered into T cells, enabling recognition and destruction of cancer cells.


What is the stock price of CARGO THERAPEUTICS INC today?

The current stock price of CRGX is 4.47 USD. The price decreased by -1.54% in the last trading session.


What is the dividend status of CARGO THERAPEUTICS INC?

CRGX does not pay a dividend.


What is the ChartMill technical and fundamental rating of CRGX stock?

CRGX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What sector and industry does CARGO THERAPEUTICS INC belong to?

CARGO THERAPEUTICS INC (CRGX) operates in the Health Care sector and the Biotechnology industry.


What is the Price/Earnings (PE) ratio of CARGO THERAPEUTICS INC (CRGX)?

CARGO THERAPEUTICS INC (CRGX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.66).


Can you provide the upcoming earnings date for CARGO THERAPEUTICS INC?

CARGO THERAPEUTICS INC (CRGX) will report earnings on 2025-11-10.